Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Medtronic
MDT
|
$580M |
| 2 |
Citigroup
C
|
$486M |
| 3 |
Cimpress
CMPR
|
$398M |
| 4 |
Broadcom
AVGO
|
$367M |
| 5 |
Apple
AAPL
|
$285M |
Top Sells
| 1 |
RAI
Reynolds American Inc
RAI
|
$348M |
| 2 |
Microsoft
MSFT
|
$337M |
| 3 |
IQVIA
IQV
|
$249M |
| 4 |
Costco
COST
|
$202M |
| 5 |
AbbVie
ABBV
|
$177M |
Sector Composition
| 1 | Technology | 23.21% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.77% |
| 4 | Industrials | 12.75% |
| 5 | Consumer Discretionary | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Ball Corp
BALL
$13.9B
| $176M | 0.11% |
4,271,901
+139,329
| +3% | +$5.75M |
|
227
Stryker
SYK
$150B
| $173M | 0.11% |
1,214,733
+195,479
| +19% | +$27.8M |
|
228
Equity Lifestyle Properties
ELS
$12B
| $172M | 0.11% |
4,038,334
+16,366
| +0.4% | +$696K |
|
229
RenaissanceRe
RNR
$11.3B
| $171M | 0.11% |
1,266,094
-24,538
| -2% | -$3.32M |
|
230
NRG Energy
NRG
$28.6B
| $171M | 0.11% |
6,671,449
+1,154,171
| +21% | +$29.5M |
|
231
Charter Communications
CHTR
$35.7B
| $169M | 0.11% |
465,582
-138,437
| -23% | -$50.3M |
|
232
Cencora
COR
$56.7B
| $169M | 0.11% |
2,038,947
-535,799
| -21% | -$44.3M |
|
233
Quest Diagnostics
DGX
$20.5B
| $169M | 0.11% |
1,801,477
+349,703
| +24% | +$32.7M |
|
234
Bristol-Myers Squibb
BMY
$96B
| $167M | 0.11% |
2,619,955
-1,014,173
| -28% | -$64.6M |
|
235
Dominion Energy
D
$49.7B
| $166M | 0.11% |
2,164,104
+491,667
| +29% | +$37.8M |
|
236
Kroger
KR
$44.8B
| $166M | 0.11% |
8,281,641
+21,381
| +0.3% | +$429K |
|
237
Kimberly-Clark
KMB
$43.1B
| $166M | 0.11% |
1,407,590
-1,068,404
| -43% | -$126M |
|
238
Sally Beauty Holdings
SBH
$1.44B
| $165M | 0.11% |
8,442,681
-434,379
| -5% | -$8.51M |
|
239
Clorox
CLX
$15.5B
| $165M | 0.11% |
1,252,545
-70,930
| -5% | -$9.36M |
|
240
Electronic Arts
EA
$42.2B
| $165M | 0.11% |
1,399,550
-25,728
| -2% | -$3.04M |
|
241
Idexx Laboratories
IDXX
$51.4B
| $165M | 0.11% |
1,062,485
-69,417
| -6% | -$10.8M |
|
|
242
AbbVie
ABBV
$375B
| $164M | 0.11% |
1,843,684
-1,989,851
| -52% | -$177M |
|
243
Williams-Sonoma
WSM
$24.7B
| $163M | 0.1% |
6,550,684
-484,146
| -7% | -$12.1M |
|
244
Middleby
MIDD
$7.32B
| $163M | 0.1% |
1,273,951
-78,914
| -6% | -$10.1M |
|
245
Waste Connections
WCN
$46.1B
| $161M | 0.1% |
2,304,564
+166,081
| +8% | +$11.6M |
|
246
Novartis
NVS
$251B
| $160M | 0.1% |
2,080,666
-55,934
| -3% | -$4.3M |
|
247
Alliant Energy
LNT
$16.6B
| $159M | 0.1% |
3,827,181
+189,180
| +5% | +$7.86M |
|
248
Xcel Energy
XEL
$43B
| $158M | 0.1% |
3,336,876
+1,067,592
| +47% | +$50.5M |
|
|
PACW
249
DELISTED
PacWest Bancorp
PACW
| $158M | 0.1% |
3,120,366
+794,113
| +34% | +$40.1M |
|
250
M&T Bank
MTB
$31.2B
| $155M | 0.1% |
965,319
+226,483
| +31% | +$36.5M |
|